MANAGEMENT,PATIENTS,CONFIRMED,NCOV,SKIP,SITE,CONTENT,PAGE,OPTIONS,LINK,SELF,CORONAVIRUS,CENTERS FOR DISEASE CONTROL,PREVENTION,TWENTY FOUR SEVEN,SAVING,LIVES,PEOPLE,PEOPLE SEARCH,SEARCH,ICON,CLOSE,FULL,TOPICS,DISEASE,SECTION,NAVIGATION,FACEBOOK,TWITTER,LINKEDIN,EMAIL,SYNDICATE,INTERIM,GUIDANCE,MINUS,RELATED,PAGES,SUMMARY,RECENT,MARCH 7,EPIDEMIOLOGIC,DATA,CHINA,INTENSIVE CARE UNIT,PEDIATRIC,CASES,SARS COV,VIRAL SHEDDING,ASYMPTOMATIC,PERSONS,REPORT,ISOLATION,STOOL,INVESTIGATIONAL DRUG,THERAPIES,CLINICAL TRIAL,ENROLLMENT,THE UNITED STATES,RECENTLY,PUBLISHED,SURVIVING,SEPSIS,RADIOGRAPHIC,TRANSMISSION BASED PRECAUTIONS,CLINICIANS,INFECTION,SEVERE ACUTE RESPIRATORY,SYNDROME,THE VIRUS,CAUSES,UPDATE,INFORMATION,REPORTS,AVAILABLE,PRESENTATION,DESCRIBE,LIMITED,HOSPITALIZED,PNEUMONIA,INCUBATION PERIOD,AT 4,DAYS,INTERQUARTILE RANGE,WIDER,RANGE,HUMAN,MERS COV,14 DAYS,REPORTED,SIGNS AND SYMPTOMS OF,THE HOSPITAL,FEVER,COUGH,MYALGIA,FATIGUE,SHORTNESS OF BREATH,ILLNESS,ONSET,PRESENT,IN 44,HOSPITAL ADMISSION,DEVELOPED,HOSPITALIZATION,LESS,RESPIRATORY SYMPTOMS,SORE THROAT,HEADACHE,SPUTUM,PRODUCTION,HEMOPTYSIS,EXPERIENCED,GASTROINTESTINAL,SYMPTOMS,DIARRHEA,NAUSEA,PRIOR,LOWER RESPIRATORY TRACT,SIGNS AND SYMPTOMS,THE FEVER,COURSE,FULLY,UNDERSTOOD,INTERMITTENT,NUMBER,IDENTIFICATION OF,SUBCLINICAL INFECTION,BASIS,DETECTION,RNA,VIRUS,THROAT SWAB,CONTACTS,RISK FACTORS,SEVERE ILLNESS,CLEAR,OLDER,CHRONIC,MEDICAL CONDITIONS,HIGHER,RISK,AS OF,FEB 11,AGED,CRITICALLY ILL,CASE FATALITY,PROPORTION,UNDERLYING,OVERALL,COMORBIDITIES,CARDIOVASCULAR DISEASE,DIABETES,CHRONIC RESPIRATORY DISEASE,HYPERTENSION,CANCER,RESPIRATORY FAILURE,SEPTIC SHOCK,MULTIPLE ORGAN DYSFUNCTION,CHILDREN,DEATHS,BE MORE,MILD,ADULTS,PRESENTING,CONGESTION,RHINORRHEA,VOMITING,RESPIRATORY,UP TO,30 DAYS,COMPLICATIONS,ACUTE RESPIRATORY DISTRESS,MONTH,SEVERITY,ASYMPTOMATIC INFECTION,THE POTENTIAL,WEEK,HALF,DYSPNEA,MEDIAN,OF 8,MEAN TIME,ARDS,SECONDARY INFECTION,SYMPTOM,INTENSIVE CARE,SUPPORT,MEDIAN AGE,VERSUS,CO MORBID,CONDITIONS,HIGH,FLOW,OXYGEN THERAPY,MECHANICAL VENTILATION,ADVANCED,ORGAN SUPPORT,ENDOTRACHEAL INTUBATION,EXTRACORPOREAL MEMBRANE,OXYGENATION,ECMO,CARDIAC,INJURY,ARRHYTHMIA,LIVER DYSFUNCTION,ACUTE KIDNEY INJURY,MULTI ORGAN FAILURE,POST MORTEM,BIOPSIES,PATIENT,DIED,PULMONARY,FINDINGS,DIFFUSE ALVEOLAR DAMAGE,OF 2,THE MAJORITY,THEREFORE,ESTIMATE,BIASED,UPWARD,THE CASE,FATALITY,AS 4,FROM ONE,HOSPITAL,ADMISSION,DIAGNOSTIC TESTING,SPECIMEN,COLLECTION,HANDLING,STORAGE,REAL TIME RT PCR,PANEL,NOVEL CORONAVIRUS,INITIAL,CONFIRMATION,TESTING,HELP,INFORM,DISCHARGE PLANNING,LABORATORY,COMMON,ABNORMALITIES,LEUKOPENIA,LEUKOCYTOSIS,LYMPHOPENIA,ELEVATED,ALANINE AMINOTRANSFERASE,ASPARTATE AMINOTRANSFERASE,LYMPHOCYTOPENIA,THROMBOCYTOPENIA,NORMAL,SERUM,PROCALCITONIN,CHEST,CT IMAGES,BILATERAL,MULTIPLE,AREAS,CONSOLIDATION,GROUND GLASS OPACITIES,DATE,STUDY,CT SCAN,PRESENTED,CT 20,INFECTIOUS,DETECTED,UPPER,CELL CULTURE,UPPER RESPIRATORY TRACT,BRONCHOALVEOLAR LAVAGE FLUID,CASE SERIES,VIRAL,COLLECTED,THE NOSE,THROAT,CYCLE,THRESHOLD,VALUES,SIMILAR,PATTERN,EXPOSURE,BLOOD,DURATION,LOWER RESPIRATORY TRACTS,EXTRAPULMONARY,POSSIBLE,WEEKS,URINE,CONTRAST,RESPIRATORY TRACT,INFECTION PREVENTION,CONTROL,RECOMMENDATIONS,PLEASE,INVESTIGATION,HEALTHCARE,SETTINGS,CLINICAL SIGNS,PROGRESSION,SHOULD,LUNG DISEASE,HEART FAILURE,CEREBROVASCULAR DISEASE,RENAL DISEASE,LIVER DISEASE,PREGNANCY,THE DECISION,MONITOR,INPATIENT,OUTPATIENT,SETTING,CASE,DECISION,DEPEND,ABILITY,ENGAGE,MONITORING,TRANSMISSION,ENVIRONMENT,REPORTING,PROMPT,IMPLEMENTATION OF,CORTICOSTEROIDS,VIRAL REPLICATION,UNLESS,REASONS,EXAMPLE,CHRONIC OBSTRUCTIVE PULMONARY,GUIDELINES,DIAGNOSIS,COMMUNITY ACQUIRED PNEUMONIA,CLINICAL PRACTICE GUIDELINE,THE AMERICAN THORACIC SOCIETY,INFECTIOUS DISEASES SOCIETY OF,SURVIVING SEPSIS CAMPAIGN,INTERNATIONAL,ORGAN DYSFUNCTION,THERAPEUTICS,ANTIVIRAL DRUGS,LICENSED,THE U S,FOOD AND DRUG ADMINISTRATION,FDA,THE NATIONAL INSTITUTES OF,HEALTH,COLLABORATORS,DEVELOPMENT OF,CANDIDATE,IN VITRO,IN VIVO,POTENTIAL,THERAPEUTIC ACTIVITY,RANDOMIZED CONTROLLED TRIALS,HUMANS,AT THIS TIME,ANTIVIRAL DRUG,ACTIVITY,INTRAVENOUS,COMPASSIONATE USE,OUTSIDE,CLINICAL TRIALS,ADAPTIVE,RANDOMIZED CONTROLLED,EXTERNAL,THE FOOD AND DRUG,ADMINISTRATION,THERAPEUTIC,TRIALS,UNDERWAY,THE ABSENCE,VACCINE,COMMUNITY,MITIGATION,PRIMARY,REDUCE,THE COMMUNITY,ADHERENCE,SPREAD,HEALTHCARE FACILITIES,SAFETY,EFFICACY,AVOIDANCE,SUPPORTIVE CARE,DISCONTINUATION,DISPOSITION,RESOURCES,HOSPITALS,HEALTHCARE PROFESSIONALS,WORLD HEALTH ORGANIZATION,AMERICAN THORACIC SOCIETY,AMERICA,CLINICAL PRACTICE GUIDELINES,ACQUIRED,CHEMOPROPHYLAXIS,INSTITUTIONAL,SEASONAL,REFERENCES,GUAN,LIANG,ZENG,YUEN,CHEN,TANG,WANG,XIANG,PENG,ZHENG,MEDICAL TREATMENT,EXPERT,GROUP,ENGL,FEB 28,EPUB AHEAD OF PRINT,HUANG,C,ZHAO,CHENG,FEATURES,INFECTED,WUHAN CHINA,THE LANCET,JAN 24,WUHAN,ONLINE,FEBRUARY 7,ZHOU,DONG,GONG,EPIDEMIOLOGICAL,DESCRIPTIVE STUDY,LANCET,JAN 30,DEBOLT,JAN 31,LI Q,DYNAMICS,JAN 29,YUAN,FAMILIAL,PERSON TO PERSON,FAMILY,BERGER,BEHRENS,EVIDENCE,RETURNING,TRAVELERS,NEW ENGLAND JOURNAL OF,